D-0201-2026 Class II Ongoing
FDA drug recall D-0201-2026 was initiated by Blossom Pharmaceuticals on Oct 31, 2025 and is designated Class II. Reason for recall: cGMP deviations The recall status is ongoing. Affected quantity: 9600 containers.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 10, 2025
- Initiation Date
- Oct 31, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9600 containers
Product description
Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation, 10 Gleshaw Street, Orangeburg, NY 10962 USA, Made in India, UPC 616784126319.
Reason for recall
cGMP deviations
Distribution pattern
USA Nationwide
Code information
Lot #: A162301, Exp. Date 9/26; A162401, Exp. Date 4/27 & A162202, Exp. Date 11/25.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0201-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026